← Back
Data updated: Mar 29, 2026
COSETTE
CardiovascularDermatologyInfectious Disease
Pharma
COSETTE is a pharmaceutical company focused on Cardiovascular, Dermatology, Infectious Disease. Key products include VYLEESI (AUTOINJECTOR).
1973
Since
79
Drugs
-
Trials
393
Approved (2yr)
Key Drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 46%
6 drugs
Dermatology 23%
3 drugs
Infectious Disease 15%
2 drugs
Immunology 8%
1 drugs
Oncology 8%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Pfizer big-pharma
Oncology, Infectious Disease, Dermatology, Immunology
Merck big-pharma
Oncology, Infectious Disease, Cardiovascular, Immunology
Baxter specialty
Infectious Disease, Cardiovascular, Oncology, Dermatology
Johnson & Johnson big-pharma
Oncology, Immunology, Infectious Disease, Cardiovascular
Novartis big-pharma
Oncology, Cardiovascular, Immunology
Active (36)
VYLEESI (AUTOINJECTOR) CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE PROMETHAZINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE TRIBENZOR IMIQUIMOD EFFIENT DIVALPROEX SODIUM CALCIPOTRIENE AZOR AMBIEN CR GRISEOFULVIN FLUTICASONE PROPIONATE BENICAR HCT BENICAR ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE EVOXAC CLOMIPHENE CITRATE KETOCONAZOLE M-ZOLE 3 COMBINATION PACK HYDROCORTISONE VALERATE DESOXIMETASONE CICLOPIROX ACYCLOVIR AMBIEN CLINDAMYCIN HYDROCHLORIDE ALBUTEROL SULFATE FLUOCINONIDE EMULSIFIED BASE PROMETHEGAN HYDROCORTISONE AND ACETIC ACID BETAMETHASONE DIPROPIONATE DOXYCYCLINE MIGERGOT NITROGLYCERIN DAPSONE NYSTATIN FLUOCINONIDE
Discontinued (42)
METRONIDAZOLE LIDOCAINE ROPINIROLE HYDROCHLORIDE SUCRALFATE PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE MOMETASONE FUROATE TAZAROTENE CLOBETASOL PROPIONATE TRIAMCINOLONE ACETONIDE LIDOCAINE HYDROCHLORIDE FLUOCINOLONE ACETONIDE SELEGILINE HYDROCHLORIDE MICONAZOLE NITRATE QUINIDINE SULFATE INDOMETHACIN PROMETHAZINE HYDROCHLORIDE PROCHLORPERAZINE CITALOPRAM HYDROBROMIDE TOLMETIN SODIUM CHLORTHALIDONE CAPTOPRIL CIMETIDINE HYDROCHLORIDE PROBAMPACIN GENTAMICIN SULFATE DESONIDE WELCHOL CAPTOPRIL AND HYDROCHLOROTHIAZIDE PINDOLOL ETHYOL BETA-VAL ACEPHEN PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE TOLAZAMIDE SELENIUM SULFIDE METAPROTERENOL SULFATE MICONAZOLE 7 COMBINATION PACK SULFANILAMIDE VAGILIA MYKACET ERYTHROMYCIN ESTOLATE TRUPHYLLINE GYNE-SULF
Company Info
- First Approval
- 1973-10-10
- Latest
- 2025-12-29
- Applications
- 129